Evogene Ltd.
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules… (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | 2026-08-26 | Tarcic Gabi | Chief Development Officer | Purchase | 1,129 | $0.60 | $677.40 | 1,129 | View | |
| 2026-08-11 | 2026-08-13 | RECANATI LEON | Director | Purchase | 460.0K | $0.64 | $292K | 1.34M | View | |
| 2026-08-04 | 2026-08-05 | RECANATI LEON | Director | Purchase | 800.0K | $0.50 | $400K | 883.9K | View |
Informational purposes only, not investment advice.
tormere.com/research/EVGN · generated 2026-10-28
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules…
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-04 | Tarcic Gabi | P | 1,129 | $677.4 |
| 2026-08-11 | RECANATI LEON | P | 460,000 | $292,100 |
| 2026-08-04 | RECANATI LEON | P | 800,000 | $400,000 |
Tormere — informational purposes only, not investment advice.